It’s a similar story each time: A line of sometimes emotional testifiers pleads for a change in direction from the Nebraska Medical Cannabis Commission.”I wouldn’t trust any of you within 100 feet of my family if I ever need you to care, because you’ve proven that you cannot be trusted,” Dominic Gillen, a supporter of medical cannabis, told the commission during the public comment portion of Monday’s meeting.Then, the commission doesn’t budge. The commission is employing stringent market controls on the total number of cultivators and even the number of plants they can grow.”We actually want it to work and not be so oversaturated that everybody goes out of business and loses their business and everything they’ve invested,” Dr. Monica Oldenburg, the commission’s chair, said.It also restricts the way patients can use cannabis: no flower, no vaping, no flavored edibles.”We don’t typically make medical decisions based on popular vote,” commissioner Lorelle Mueting said. “We make medical decisions based on science and research. And although 71% of Nebraskans voted for medical cannabis, we still owe it to them to provide it in a medical form. That’s not going to do more harm than good.”At that point, looks of disbelief wrinkled the faces of the dozens in attendance. These discussions took place just week after hundreds of comments against the regulations came pouring in from across Nebraska. Overwhelmingly, those comments called on the commissioners to loosen the rules.”You guys are getting destroyed,” Landon Crow, a supporter of medical cannabis, said. “It’s a 71% landslide.”All three commissioners skipped last week’s legislative hearing, which was meant to weigh how successfully the commission has been rolling out medical cannabis. There, State Sen. John Cavanaugh contended the regulations actually violate the law by capping how much THC a patient can possess and ruling that only practitioners who are primarily in Nebraska can recommend cannabis.”The Medical Cannabis Commission has no authority to regulate any conduct explicitly allowed under the Patient Protection Act,” Cavanaugh said on Friday.Nevertheless, the commissioners are keeping those rules in place, a move that could open them up to lawsuits down the road. The next meeting is set for Dec. 2.